Eversept Partners, LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
56
Total Value
973407155
Accession Number
0001697013-25-000005
Form Type
13F-HR
Manager Name
Eversept-Partners-Lp
Data Enrichment
100% identified
56 identified0 unidentified

Holdings

56 positions
Manager:
Search and click to pin securities to the top
Page 1 of 3
Natera, Inc.
Shares:893.7K
Value:$126.4M
GSK plc
Shares:2.6M
Value:$101.6M
INVESCO QQQ TRUST, SERIES 1
Shares:123.6K
Value:$58.0M
HCA Healthcare, Inc.
Shares:152.5K
Value:$52.7M
Syndax Pharmaceuticals Inc
Shares:4.2M
Value:$51.7M
Vera Therapeutics, Inc.
Shares:1.9M
Value:$45.6M
SPDR S&P 500 ETF TRUST
Shares:76.9K
Value:$43.0M
REVVITY, INC.
Shares:299.1K
Value:$31.6M
HEALTHEQUITY, INC.
Shares:352.0K
Value:$31.1M
Inspire Medical Systems, Inc.
Shares:186.4K
Value:$29.7M
Protagonist Therapeutics, Inc
Shares:547.1K
Value:$26.5M
COMMUNITY HEALTH SYSTEMS INC
Shares:8.5M
Value:$22.8M
ZimVie Inc.
Shares:2.1M
Value:$22.5M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Shares:1.4M
Value:$21.7M
Vaxcyte, Inc.
Shares:557.1K
Value:$21.0M
BRUKER CORP
Shares:499.2K
Value:$20.8M
CENTENE CORP
Shares:340.3K
Value:$20.7M
Viridian Therapeutics, Inc.\DE
Shares:1.4M
Value:$18.6M
NEUROCRINE BIOSCIENCES INC
Shares:167.2K
Value:$18.5M
UNITED THERAPEUTICS Corp
Shares:57.5K
Value:$17.7M